Medifast, Inc. (MED) Misses Q4 EPS by 13c; Issues Mixed Guidance
Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.08, $0.13 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $69 million versus the consensus estimate of $70.97 million.
Medifast, Inc. sees Q1 2012 EPS of $0.36-$0.38, versus the consensus of $0.45. Medifast, Inc. sees Q1 2012 revenue of $86.5-$88.5 million, versus the consensus of $83.4 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Medifast, Inc. sees Q1 2012 EPS of $0.36-$0.38, versus the consensus of $0.45. Medifast, Inc. sees Q1 2012 revenue of $86.5-$88.5 million, versus the consensus of $83.4 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.